These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8587349)

  • 1. Ventricular tachycardias induced by intracoronary administration of endothelin-1 in dogs.
    Tóth M; Solti F; Merkely B; Kékesi V; Horkay F; Szokodi I; Juhász-Nagy A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S153-5. PubMed ID: 8587349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects.
    Kiss O; Zima E; Soós P; Kékesi V; Juhász-Nagy A; Merkely B
    Life Sci; 2004 Jun; 75(5):537-48. PubMed ID: 15158364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressed monophasic action potential alternans before the onset of ventricular arrhythmias induced by intracoronary bolus administration of endothelin-1 in dogs.
    Merkely B; Vágó H; Kiss O; Zima E; Szücs G; Gellér L; Juhász-Nagy A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():219S-222S. PubMed ID: 12193090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of endothelin-induced malignant ventricular arrhythmias in dogs.
    Merkely B; Gellér L; Tóth M; Kiss O; Kékesi V; Solti F; Vecsey T; Horkay F; Tenczer J; Juhász-Nagy A
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S437-9. PubMed ID: 9595506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow.
    Salvati P; Chierchia S; Dho L; Ferrario RG; Parenti P; Vicedomini G; Patrono C
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):1007-14. PubMed ID: 1714004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of intrapericardial infusion of endothelin-1.
    Gellér L; Merkely B; Szokodi I; Szabó T; Vecsey T; Juhász-Nagy A; Tóth M; Horkay F
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):151-6. PubMed ID: 9474663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic follow-up in dogs receiving intracoronary ethyl alcohol injection.
    Hua W; Wang FZ; Wan LL; Chen X; Sun RL
    Chin Med J (Engl); 1992 Jun; 105(6):457-61. PubMed ID: 1451546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of experimental diabetes on endothelin-induced ventricular arrhythmias in dogs.
    Pósa I; Horkay F; Seres L; Skoumal R; Kováts T; Balogh E; de Châtel R; Tóth M; Kocsis E
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S380-2. PubMed ID: 15838325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil reduces the arrhythmogenic effect of endothelin.
    Solti F; Tóth M; Merkely B; Kékesi V; Gellér L; Szokodi I; Horkay F; Juhász-Nagy A
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S386-7. PubMed ID: 9595491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradycardia increases the arrhythmogenic effect of endothelin.
    Tóth M; Solti F; Merkely B; Kékesi V; Szokodi I; Horkay F; Juhász-Nagy A
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S431-3. PubMed ID: 9595504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1.
    Merkely B; Szabó T; Gellér L; Kiss O; Horkay F; Raschack M; Juhász-Nagy A
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S314-6. PubMed ID: 11078407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs.
    Muramatsu K; Tomoike H; Ohara Y; Egashira S; Nakamura M
    Heart Vessels; 1991; 6(4):191-6. PubMed ID: 1800477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early afterdepolarization and cesium chloride induced ventricular arrhythmias].
    Zheng LR
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):369-71, 390. PubMed ID: 1307980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased monophasic action potential dispersion in endothelin-1-induced ventricular arrhythmias.
    Gellér L; Merkely B; Lang V; Szabó T; Fazekas L; Kékesi V; Kiss O; Horkay F; Schaldach M; Tóth M; Juhász-Nagy A
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S434-6. PubMed ID: 9595505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of endothelin-1 and big endothelin-1 levels and action potential duration during myocardial ischemia-reperfusion in dogs with and without ventricular fibrillation.
    Vágó H; Soós P; Zima E; Gellér L; Keltai K; Róka A; Kékesi V; Juhász-Nagy A; Merkely B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S376-9. PubMed ID: 15838324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.
    Kiss O; Gellér L; Merkely B; Szabó T; Raschack M; Seres L; Zima E; Juhász-Nagy A; Horkay F
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S317-9. PubMed ID: 11078408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion.
    Kelly RF; Hursey TL; Schaer GL; Piotrowski MJ; Dee SV; Parrillo JE; Hollenberg SM
    J Investig Med; 1996 Dec; 44(9):575-82. PubMed ID: 9035612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of tetramethyl pyrazine on coronary vasoconstriction induced by endothelin-1 in dogs].
    Pu Z; Zhu W; Jing Z; Zeng Z; Zuo W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):133-7. PubMed ID: 9208604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias.
    Horkay F; Gellér L; Kiss O; Szabó T; Vagó H; Kékesi V; Juhász-Nagy A; Merkely B
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S320-2. PubMed ID: 11078409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.